NCT06301854

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

A Multicenter, Open Study to Evaluate the Long-term Safety and Efficacy of TPN171H in Patients With Erectile Dysfunction

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 472 (actual)
• Sponsor: Vigonvita Life Sciences · Industry
• Sex: Male
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, open study to evaluate the long-term safety and efficacy of TPN171H in men with erectile dysfunction.

Conditions

• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	TPN171H	10 mg/ time, as needed, it is recommended to take warm water within 0.5 to 4 hours before sexual activity.

Timeline

• Start date: 2024-04-12
• Primary completion: 2025-06-05
• Completion: 2025-06-05
• First posted: 2024-03-08
• Last updated: 2025-07-25

Locations

34 sites across 1 country: China